2012Journal of Chinese Practical Diagnosis and TherapyRequires access

Construction of eukaryotic expression plasmid of pcDNA3.1/VEGF-B-EGFP and its expression in bone marrow mesenchymal stem cells

Hui Wang

Open publisher page 0 citations

Abstract

Objective To detect the expression of vascular endothelial cell growth factor(VEGF)-B in human bone marrow mesenchymal stem cells(MSCs).Methods The recombinant plasmids of pcDNA 3.1/VEGF-B-EGFP were obtained by polymerase chain reaction(PCR) amplification,splicing,and insertion of complementary deoxyribonucleic acid(cDNA) fragments of VEGF-B and EGFP.The target gene was transferred to the third cultured MSCs(pcDNA 3.1/VEGF-B-EGFP transferred group) by using of cationic liposome mediated gene transfection technique.EGFP expression was detected with fluorescence microscopy,and the transfection rate was determined with flow cytometry.Reverse transcriptase PCR(RT-PCR),Western blot and other techniques were used to detect the expression of VEGF-B gene.Results In pcDNA 3.1/VEGF-B-EGFP transferred group,bright green fluorescence was observed with fluorescence microscopy 24 hours after transfection in MSCs,the rate of transfection analyzed with flow cytometry was 15%.RT-PCR results showed that the genome of VEGF-B transferred MSCs contained a 590bp specific fragment of VEGF-B gene.Western blot results proved VEGF-B protein expression in MSCs transferred by VEGF-B.Conclusion The generation of eukaryotic expression plasmid carrying VEGF-B gene and its expression in MSCs provide a sound basis for the combination of VEGF-B gene therapy and autologous MSCs transplantation in ischemic heart disease.

About this research paper

What this paper is about

Objective To detect the expression of vascular endothelial cell growth factor(VEGF)-B in human bone marrow mesenchymal stem cells(MSCs).Methods The recombinant plasmids of pcDNA 3.1/VEGF-B-EGFP were obtained by polymerase chain reaction(PCR) amplification,splicing,and insertion of complementary deoxyribonucleic acid(cDNA) fragments of VEGF-B and EGFP.The target gene was transferred to the third cultured MSCs(pcDNA 3.1/VEGF-B-EGFP transferred group) by using of cationic liposome mediated gene transfection technique.EGFP expression was detected with fluorescence microscopy,and the transfection rate was determined with flow cytometry.Reverse transcriptase PCR(RT-PCR),Western blot and other techniques were used to detect the expression of VEGF-B gene.Results In pcDNA 3.1/VEGF-B-EGFP transferred group,bright green fluorescence was observed with fluorescence microscopy 24 hours after transfection in MSCs,the rate of transfection analyzed with flow cytometry was 15%.RT-PCR results showed that the genome of VEGF-B transferred MSCs contained a 590bp specific fragment of VEGF-B gene.Western blot results proved VEGF-B protein expression in MSCs transferred by VEGF-B.Conclusion The generation of eukaryotic expression plasmid carrying VEGF-B gene and its expression in MSCs provide a sound basis for the combination of VEGF-B gene therapy and autologous MSCs transplantation in ischemic heart disease.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To detect the expression of vascular endothelial cell growth factor(VEGF)-B in human bone marrow mesenchymal stem cells(MSCs).Methods The recombinant plasmids of pcDNA 3.1/VEGF-B-EGFP were obtained by polymerase chain reaction(PCR) amplification,splicing,and insertion of complementary deoxyribonucleic acid(cDNA) fragments of VEGF-B and EGFP.The target gene was transferred to the third cultured MSCs(pcDNA 3.1/VEGF-B-EGFP transferred group) by using of cationic liposome mediated gene transfection technique.EGFP expression was detected with fluorescence microscopy,and the transfection rate was determined with flow cytometry.Reverse transcriptase PCR(RT-PCR),Western blot and other techniques were used to detect the expression of VEGF-B gene.Results In pcDNA 3.1/VEGF-B-EGFP transferred group,bright green fluorescence was observed with fluorescence microscopy 24 hours after transfection in MSCs,the rate of transfection analyzed with flow cytometry was 15%.RT-PCR results showed that the genome of VEGF-B transferred MSCs contained a 590bp specific fragment of VEGF-B gene.Western blot results proved VEGF-B protein expression in MSCs transferred by VEGF-B.Conclusion The generation of eukaryotic expression plasmid carrying VEGF-B gene and its expression in MSCs provide a sound basis for the combination of VEGF-B gene therapy and autologous MSCs transplantation in ischemic heart disease.

Key concepts: Molecular biology, Transfection, Mesenchymal stem cell, Flow cytometry, Green fluorescent protein, Vascular endothelial growth factor, Plasmid, Biology

Related papers

Back to paper searchBrowse research topicsOriginal source
Construction of eukaryotic expression plasmid of pcDNA3.1/VEGF-B-EGFP and its expression in bone marrow mesenchymal stem cells — Research Paper | ScholarLens